HomepageICUI • NASDAQ
add
ICU Medical Inc
Vorige slotkoers
$Â 154,35
Dag-range
$Â 151,92 - $Â 156,37
Jaar-range
$Â 86,80 - $Â 196,26
Beurswaarde
3,82Â mld. USD
Gem. volume
215,34K
Koers/winst
-
Dividendrendement
-
Primaire beurs
NASDAQ
Marktnieuws
.INX
0,60%
4,60%
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
(USD) | sep 2024info | Wijziging j-o-j |
---|---|---|
Opbrengst | 589,13Â mln. | 6,47% |
Bedrijfskosten | 183,74Â mln. | 8,41% |
Netto inkomsten | -32,98Â mln. | -555,69% |
Netto winstmarge | -5,60 | -527,48% |
Winst per aandeel | 1,59 | 1,27% |
EBITDA | 76,79Â mln. | 5,47% |
Effectief belastingtarief | -83,97% | — |
Balans
Totale activa
Totale passiva
(USD) | sep 2024info | Wijziging j-o-j |
---|---|---|
Contanten en kortetermijnbeleggingen | 324,84Â mln. | 40,82% |
Totale activa | 4,31Â mld. | -1,64% |
Totale passiva | 2,26Â mld. | -0,97% |
Totaal aandelenvermogen | 2,05 mld. | — |
Uitstaande aandelen | 24,48 mln. | — |
Koers-boekwaardeverhouding | 1,84 | — |
Rendement op activa | 1,23% | — |
Rendement op kapitaal | 1,42% | — |
Kasstroom
Nettomutatie in liquide middelen
(USD) | sep 2024info | Wijziging j-o-j |
---|---|---|
Netto inkomsten | -32,98Â mln. | -555,69% |
Operationele kasstroom | 36,10Â mln. | 2,66% |
Kasstroom uit beleggingen | -22,86Â mln. | 6,72% |
Kasstroom uit financiering | -10,38Â mln. | -62,29% |
Nettomutatie in liquide middelen | 9,86Â mln. | 655,86% |
Vrije kasstroom | 46,98Â mln. | 70,19% |
Over
ICU Medical, Inc. is a medical technology company based in San Clemente, California. ICU Medical products are designed to prevent bloodstream infections and protect healthcare workers from exposure to infectious diseases or hazardous drugs. ICU Medical product line includes intravenous therapy (IV) products, pumps, needle-free vascular access devices, custom infusion sets, closed system hazardous drug handling devices and systems, sensor catheters, needle-free closed blood sampling systems, and hemodynamic monitoring systems.
ICU Medical products are designed to prevent bloodstream infections and protecting healthcare workers from exposure to infectious diseases or hazardous drugs. In addition, the company's IV medication compounding and delivery products are designed to improve medication and dosing accuracy and improve clinical workflows. In 2014 ICU Medical was named one of the 100 Most Trustworthy Companies in America by Forbes Magazine. Wikipedia
CEO
Opgericht
1984
Hoofdvestiging
Website
Werknemers
14.000